Running summarizing tools on a new article
Check the paper below, then start its synthesis.
Privacy Interests in Prescription Data, Part I: Prescriber Privacy
Patricia Kosseim (Dalhousie University, Genome Canada), Khaled El Emam (Children's Hospital of Eastern Ontario)
Abstract: For several years, concern has been growing about privacy implications that arise from using and disclosing prescription data. Some patterns or practices provide pharmaceutical companies with the historical trends they need to better target their marketing efforts aimed at individual physicians through more intense, precise, and unique detailing strategies. In the first of a two part-article, the authors focus the privacy implications arising from the sale or transfer of prescription data, in respect to prescribers in Canada and the US.